BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8146902)

  • 21. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
    Green WS; Toy P; Bozic KJ
    J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.
    Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E
    CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative blood salvage: the missing link in providing a safe and effective blood transfusion service.
    Semmens JB; Lawrence-Brown MM; Miles LE; Hellings MJ
    Med J Aust; 2000 Sep; 173(5):266-8. PubMed ID: 11144331
    [No Abstract]   [Full Text] [Related]  

  • 24. Crossover use of donated blood for autologous transfusion: report of the Council on Scientific Affairs, American Medical Association.
    Blum LN; Allen JR; Genel M; Howe JP
    Transfusion; 1998 Sep; 38(9):891-5. PubMed ID: 9738632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the cost of autologous erythrocyte concentrates in a hospital].
    Gouëzec H; Tardivel R; Danic B; Ballay JL; Malledant Y
    Cah Anesthesiol; 1996; 44(5):451-4. PubMed ID: 9183429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Autologous Blood Donation: Waning Indications in an Era of Improved Blood Safety.
    Vassallo R; Goldman M; Germain M; Lozano M;
    Transfus Med Rev; 2015 Oct; 29(4):268-75. PubMed ID: 26006319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost effectiveness of preoperative autologous blood donations.
    Etchason J; Petz L; Keeler E; Calhoun L; Kleinman S; Snider C; Fink A; Brook R
    N Engl J Med; 1995 Mar; 332(11):719-24. PubMed ID: 7854380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
    Blumberg N; Kirkley SA; Heal JM
    Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies to avoid the risks of blood transfusion: are they widely applied in Australia?
    McGrath KM
    Med J Aust; 1995 Oct; 163(7):342-3. PubMed ID: 7565255
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion.
    Vamvakas EC
    Transfusion; 2000 Mar; 40(3):384-7. PubMed ID: 10738045
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversies in transfusion medicine: is autologous blood transfusion worth the cost? Pro.
    Popovsky MA
    Transfusion; 1994 Aug; 34(8):737. PubMed ID: 7980817
    [No Abstract]   [Full Text] [Related]  

  • 32. Autologous blood transfusion in Auckland.
    Theakston E; Woodfield DG
    N Z Med J; 1992 Nov; 105(946):470-2. PubMed ID: 1436874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Pro.
    Goldfinger D; Haimowitz M
    Transfusion; 1994 Jan; 34(1):75-8. PubMed ID: 8273136
    [No Abstract]   [Full Text] [Related]  

  • 34. The implications of cost-effectiveness for autologous blood procurement.
    Adegboyega PA
    Arch Pathol Lab Med; 1994 Dec; 118(12):1168-9. PubMed ID: 7979905
    [No Abstract]   [Full Text] [Related]  

  • 35. A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood.
    Roberts WA; Kirkley SA; Newby M
    Anesth Analg; 1996 Jul; 83(1):129-33. PubMed ID: 8659723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures.
    Goodnough LM; Grishaber JE; Birkmeyer JD; Monk TG; Catalona WJ
    Urology; 1994 Aug; 44(2):226-31. PubMed ID: 8048198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Secondary costs of the disposition of preoperatively withdrawn autologous blood preserves].
    Diekamp U
    Beitr Infusionsther Transfusionsmed; 1994; 32():517-9. PubMed ID: 9480155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the term "cost-effectiveness".
    Lubarsky DA
    J Clin Anesth; 1997 Nov; 9(7):603-4. PubMed ID: 9347442
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous transfusion and reducing allogeneic blood exposure.
    Contreras M; Chapman CE
    Arch Dis Child; 1994 Aug; 71(2):105-7. PubMed ID: 7944527
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
    Canan CE; Myers JA; Owens RK; Crawford CH; Djurasovic M; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
    Spine (Phila Pa 1976); 2013 Apr; 38(8):703-8. PubMed ID: 23044618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.